Arcadia Biosciences, Inc. 4

4 · Arcadia Biosciences, Inc. · Filed Sep 11, 2015

Form 4

Period: 2015-09-11

VP Product Development

Transactions

Sale
Common Stock
2015-09-11$4.92/sh−1,068$5,253→ 14,760 total
Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-11−2,958→ 0 total
Exercise: $0.44Exp: 2015-12-31→ Common Stock (2,958 underlying)
Exercise/Conversion
Common Stock
2015-09-11$0.44/sh+2,958$1,302→ 15,828 total

Footnotes (3)

[F1]The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person on June 14, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
[F2]This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]The option is fully exercisable as of the date hereof.

Documents

1 file